News & Updates

Print this page Facebook Twitter Google+ Email

The Gastroenterological Society of Australia (GESA) have published a January 2017 update of the hepatitis C virus infection consensus statement.

South Australian hepatitis B community education projects are but a small selection of the 40 projects progressively being implemented Australia-wide.

As Australians with hepatitis C are being cured at unprecedented rates, those living with hepatitis B are looking forward to a new treatment which promises the same efficacy as current drugs but with less toxic side effects.

The Australian Medical Association (AMA) has called for clean needle programs to be introduced in prisons to protect both staff and inmates and reduce the spread of blood borne viruses.

Highlights - Hepatitis B Community Education, Hep B treatment uptake in SA, Celebrations with the Big Issue, LiveR Life comes to SA, AMA calls for needle exchange program in prisons

Another hepatitis C treatment option has been added to the Pharmaceutical Benefits Scheme (PBS).

Hepatitis SA's Singing O'livers send greetings in 40 degree heat...

The Pharmaceutical Benefits Advisory Committee (PBAC) has given positive recommendations for PBS listing for more hepatitis C direct-acting antiviral drugs.

The national organisation representing people who use drugs, AIVL, has applauded the Australian Greens' courageous leadership in adopting an evidence based drug policy that focuses on saving lives.

Misinformation and hysteria over saliva have resurfaced again as South Australians waded into the Du Plessiss ball tampering debate.

The Federal Government’s response to the 'Silent Disease' inquiry into hepatitis C in Australia falls well short of what anyone living with hepatitis C could have hoped.

A unique longitudinal real life study on entecavir-treated children and adolescents have found that HBV DNA results at six and twelve months after starting treatment, are predictors of viral suppression.

Search Hepatitis SA